Mays Cancer Center: Targeting certain molecular interactions could yield new strategies for treating prostate cancer

Molecular activity of androgen receptors could hold key to new therapeutic approaches to prostate cancer, according to research led by Mays Cancer Center of The University of Texas Health Science Center at San Antonio. SAN ANTONIO, Oct. 20, 2023 /PRNewswire-PRWeb/ -- Research led by Mays...
Source: PRWeb: Medical Pharmaceuticals - Category: Pharmaceuticals Tags: SVY Source Type: news